|
Image
|
William A. Clark, Ph.D. Vice President, Science & Strategic Alliances Dr. Clark directs and negotiates research, collaborative, alliance, service, and consulting arrangements with pharmaceutical and biotechnology companies, universities, and government laboratories. He also oversees out- and in-licensing of reagents and technologies to and from partner laboratories across the globe, and directs PBL's intellectual property and business development efforts. Dr. Clark joined PBL as Section Head of Protein Biochemistry where he led a team of scientists in the purification of recombinant novel and native interferons and monoclonal antibodies for preclinical development, research use, and commercial sale. Subsequently as Director of Drug Discovery and Development he directed protein biochemistry, genetic engineering, and drug delivery teams to advance the preclinical development of novel interferon-based therapeutics and achieve Small Business Innovation Research grant goals. Dr. Clark received his Bachelor of Science in chemistry from Boston College and enjoyed several years developing new consumer products at Lehn & Fink Products Corp., a division of Sterling Drug. He holds a Master of Philosophy and Ph.D. in pharmacology from Yale University where he specialized in in vivo. neuropharmacology supported, in part, through a competitive predoctoral NRSA fellowship. Dr. Clark completed postdoctoral training in signal transduction/reconstitution of purified G proteins and GPCRs under two awards, a competitive NIGMS PRAT fellowship and an NIH IRTA fellowship, both at the National Institutes of Health where he later accepted a Staff Scientist position. |